Argeris N. Karabelas, Director at Valeant Pharmaceuticals International, Inc. (VRX), bought 4,000 shares at $24.65 ($99K) on 2016-08-11, disclosed to the SEC on 2016-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |